Autolus
Autolus develops and sells CAR-T cell therapies for cancer, including the approved therapy AUCATZYL.
autolus.com ↗Why it's here
Reported $74.3M AUCATZYL net product revenue in 2025 and grew to 752 full-time employees from 647 a year earlier.
source: sec.gov- Focus
- Cell therapy
- Team size
- 501-1000 people
- London office
- The Mediaworks, 191 Wood Lane, London W12 7FP, Hammersmith and Fulham W12 7FPsource: sec.gov
- London presence
- HQsource: sec.gov
- Investors
- Nearest station
- White City, 292 m
- Companies House
- AUTOLUS THERAPEUTICS PLC (11185179, active)Incorporated 2 Feb 2018 · SIC 64209, 72110
- Visas
- Licensed visa sponsor, listed as Autolus Ltdsource: gov.uk
Verified 7 Oct 2026. How we verify · Suggest a fix
For Autolus
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/autolus"><img src="https://londonmempool.co.uk/badge/autolus.svg" alt="Autolus is listed on London Mempool" width="337" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.